MAPK8 and neuroblastoma: Therefore, these results revealed how JNK signaling dynamics represents an innovative type of model-based biomarker that efficiently predicts neuroblastoma patient prognostic across different individual molecular backgrounds defined by conventional single gene biomarkers.